Insight

Belén Garijo: Why do I choose to work at Merck Group?

Belén Garijo/LinkedIn

Nov 7, 2024, 15:40

Belén Garijo: Why do I choose to work at Merck Group?

Belén Garijo, Chair of the Executive Board and CEO of Merck Group, shared a post on LinkedIn:

“Why do I choose to work at Merck Group?

It´s simple: I believe our amazing company is uniquely positioned to make life brighter, healthier, and more sustainable for millions of people worldwide.

Today, with the launch of our Vision – Sparking Discovery, Elevating Humanity – I can proudly say this ambition has become more than just a statement.

It´s now a promise to the millions of customers and patients who depend upon us for innovation and impact.

As a globally diversified science and technology company with leading positions in Life Science, Healthcare, and Electronics, our 63,000-strong team needs a North Star to guide us forward in the right direction together.

Our Vision reaffirms our unwavering belief in science and technology as a powerful force for good.

It also conveys our commitment to relentlessly create transformative solutions that address the needs of this generation AND the next.

Please join me in standing behind our Vision. It will make us an even more powerful force as we responsibly drive science into a vibrant new era of discovery.”

Belén Garijo is the Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. She joined the company in 2011 as Chief Operating Officer of the Biopharma business, becoming President and CEO of Healthcare in 2015. In July 2020, Belén Garijo was appointed Vice Chairman of the Executive Board and Deputy CEO in addition to her role as CEO of the Healthcare business. She moved from Deputy CEO to CEO in May 2021. Under her leadership, Healthcare at Merck KGaA, Darmstadt, Germany, has become a key player in the area of oncology, immunology and immuno-oncology, after the profound repositioning of the portfolio, the reorganization of R&D and the transformation of the commercial model.

Before joining Merck, Belén Garijo served as the Senior Vice President of Global Operations Europe at Sanofi-Aventis and Global Integration Leader of Genzyme after its acquisition by Sanofi. She previously held several local and global executive positions, both in R&D and commercial, at various companies at the forefront of the Healthcare sector. She started her career as a practicing physician at La Paz hospital in Madrid before moving to the pharmaceutical industry. She is a medical doctor, specialized in clinical pharmacology.